Stockreport

Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM [Yahoo! Finance]

Organogenesis Holdings Inc. - Class A  (ORGO) 
Last organogenesis holdings inc. - class a earnings: 3/9 04:05 pm Check Earnings Report
PDF Results strengthen existing clinical evidence supporting future coverage CANTON, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), [Read more]